A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the safety of three doses of oxybutynin for the treatment of urge urinary incontinence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: FemmePharma Global Healthcare, Inc.
• Treatments: Mandelic Acids; Oxybutynin

Criteria

Inclusion Criteria:

• Females 18 to 75 years of age

• Has reported symptoms of urge urinary incontinence/overactive bladder

Exclusion Criteria:

• Is pregnant or lactating

• Has had lower urinary tract surgery within 6 months prior to Screening

• Has a history of urinary retention